BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22318548)

  • 21. Transforming Growth Factor β1 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of Connective Tissue Growth Factor.
    Liu H; Wang S; Ma W; Lu Y
    Cell Biochem Biophys; 2015 Dec; 73(3):775-81. PubMed ID: 27259324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
    Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
    World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
    Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
    Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis.
    Umer M; Qureshi SA; Hashmi ZY; Raza A; Ahmad J; Rahman M; Iqbal M
    Virol J; 2014 Jun; 11():117. PubMed ID: 24947038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study.
    El-Houseini ME; Ismail A; Abdelaal AA; El-Habashy AH; Abdallah ZF; Mohamed MZ; El-Hadidi M; Cho WCS; Ahmed H; Al-Shafie TA
    Biochemistry (Mosc); 2019 Aug; 84(8):941-953. PubMed ID: 31522676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.
    Xiu M; Liu YH; Brigstock DR; He FH; Zhang RJ; Gao RP
    World J Gastroenterol; 2012 Dec; 18(47):7070-8. PubMed ID: 23323010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C.
    Miyoshi K; Ikebuchi Y; Ishida C; Okamoto K; Murawaki Y
    Intern Med; 2014; 53(14):1461-8. PubMed ID: 25030555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.
    George J; Tsutsumi M; Tsuchishima M
    J Cell Mol Med; 2017 Dec; 21(12):3821-3835. PubMed ID: 28782260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
    Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
    Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection.
    Kim HG; Chung YH; Song BC; Kim J; Yang SH; Lee YS; Suh DJ
    Korean J Intern Med; 2000 Dec; 15(3):165-70. PubMed ID: 11242803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
    Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M
    Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B virus X protein promotes proliferation and upregulates TGF-beta1 and CTGF in human hepatic stellate cell line, LX-2.
    Guo GH; Tan DM; Zhu PA; Liu F
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):59-64. PubMed ID: 19208517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY; Park YN; Kim H; Park C
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.